CBO estimates that it would cost $1.5 billion to the federal government in the first year alone, rising to $6.1 billion in 2034 (see figure 1)
Today, around 2 million people are sourcing GLP-1s online, thanks to the boom in online providers offering these compounded drugs and the relatively few hoops telehealth patients need to jump through to get them
Muscle Guard is built around that plan
When it comes to private or employer-sponsored plans, these only provide GLP-1 weight-loss drug coverage for 13.7 million people, according to the database
Our program is designed to be accessible to anyone interested in pursuing a healthier lifestyle and achieving their weight loss goals
Semaglutide has been associated with early worsening of diabetic retinopathy in clinical trials, particularly in patients with pre-existing retinopathy and rapid improvement in glycaemic control